IDiyas

For the Inventor, By the Inventor

Somerset, NJ, United States of America

Iwan Suwandi Gunawan

USPTO Granted Patents = 16 

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 102(Granted Patents)


Company Filing History:

goldMedal16 out of 1,309 
 
Wyeth
 patents

Years Active: 2002-2010

Loading Chart...
16 patents (USPTO):
1. 7705030 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation (2010-04-27),
2. 7700602 - Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase (2010-04-20),
3. 7563796 - Diphenylimidazopyrimidines as inhibitors of β-secretase (2009-07-21),
4. 7531564 - Substituted benzoxazoles as estrogenic agents (2009-05-12),
5. 7482349 - Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase (2009-01-27),
6. 7456186 - Diphenylimidazopyrimidines as inhibitors of β-secretase (2008-11-25),
7. 7417047 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation (2008-08-26),
8. 7148247 - Substituted benzoxazoles as estrogenic agents (2006-12-12),
9. 7129258 - Substituted benzoxazoles as estrogenic agents (2006-10-31),
10. 6960607 - Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents (2005-11-01),
11. 6884814 - Phenyl benzisoxazoles as estrogenic agents (2005-04-26),
12. 6844358 - Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia (2005-01-18),
13. 6794403 - Substituted benzoxazoles as estrogenic agents (2004-09-21),
14. 6569873 - Azolidines as beta-3 adrenergic receptor agonists (2003-05-27),
15. 6509360 - Penyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia (2003-01-21),

Title: Inspiring Innovation: The Journey of Inventor Iwan Suwandi Gunawan

Introduction:

Inventor Iwan Suwandi Gunawan, based in Somerset, NJ, is a visionary individual whose passion for innovation and commitment to excellence have left a remarkable impact on the world of technology. With 16 patents to his name, Iwan Suwandi Gunawan is shaping the future with his groundbreaking inventions.

Latest Patents:

Among his latest patents is the creation of Amino-5-(5-membered)hetero-arylimidazolone compounds, aimed at β-secretase modulation. These compounds show promise in inhibiting BACE and treating β-amyloid deposits and neurofibrillary tangles. Additionally, his work on Amino-5,5-diphenylimidazolone derivatives demonstrates potential for therapeutic treatment of diseases characterized by elevated β-amyloid deposits.

Career Highlights:

Iwan Suwandi Gunawan is a valuable asset to Wyeth, where he applies his inventive prowess to drive innovation forward. His dedication to creating impactful solutions has earned him recognition within the company and beyond. Through his patents, he continues to push the boundaries of what is possible in the realm of technology.

Collaborations:

Collaborating with talented individuals such as Michael Sotirios Malamas and James Joseph Erdei, Iwan Suwandi Gunawan has fostered a culture of creativity and ingenuity. Together, they have worked on projects that have the potential to revolutionize the industry and improve the lives of many.

Conclusion:

In conclusion, Iwan Suwandi Gunawan's relentless pursuit of excellence and his unwavering passion for innovation serve as a beacon of inspiration for aspiring inventors worldwide. His contributions to the field of technology are paving the way for a brighter and more technologically advanced future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…